These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 9722815)

  • 1. Drug abuse treatment as AIDS prevention.
    Metzger DS; Navaline H; Woody GE
    Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):97-106. PubMed ID: 9722815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outreach-based HIV prevention for injecting drug users: a review of published outcome data.
    Coyle SL; Needle RH; Normand J
    Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):19-30. PubMed ID: 9722807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human immunodeficiency virus prevention and the potential of drug abuse treatment.
    Metzger DS; Navaline H
    Clin Infect Dis; 2003 Dec; 37 Suppl 5():S451-6. PubMed ID: 14648463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methadone treatment protects against HIV infection: two decades of experience in the Bronx, New York City.
    Hartel DM; Schoenbaum EE
    Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):107-15. PubMed ID: 9722816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV risk reduction in outpatient drug abuse treatment: individual and geographic differences.
    Broome KM; Joe GW; Simpson DD
    AIDS Educ Prev; 1999 Aug; 11(4):293-306. PubMed ID: 10494354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV diagnoses among injection-drug users in states with HIV surveillance--25 states, 1994-2000.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2003 Jul; 52(27):634-6. PubMed ID: 12855944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-associated behaviors among injecting-drug users--23 Cities, United States, May 2005-February 2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Apr; 58(13):329-32. PubMed ID: 19357632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia.
    Vicknasingam B; Narayanan S; Navaratnam V
    Drug Alcohol Rev; 2009 Jul; 28(4):447-54. PubMed ID: 19594801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community-based outreach HIV intervention for street-recruited drug users in Madras, India.
    Kumar MS; Mudaliar S; Daniels D
    Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):58-66. PubMed ID: 9722810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of risk behaviors for HIV infection among adults--United States, 1997.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Apr; 50(14):262-5. PubMed ID: 11411830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City.
    Des Jarlais DC; Arasteh K; Perlis T; Hagan H; Abdul-Quader A; Heckathorn DD; McKnight C; Bramson H; Nemeth C; Torian LV; Friedman SR
    AIDS; 2007 Jan; 21(2):231-5. PubMed ID: 17197815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health services research: drug use and human immunodeficiency virus in the United States.
    Flanzer J
    Clin Infect Dis; 2003 Dec; 37 Suppl 5():S439-44. PubMed ID: 14648461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-associated risk behaviour among drug users at drug rehabilitation centres.
    Fauziah MN; Anita S; Sha'ari BN; Rosli BI
    Med J Malaysia; 2003 Jun; 58(2):268-72. PubMed ID: 14569748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiles of self-reported HIV-risk behaviors among injection drug users in methadone maintenance treatment, detoxification, and needle exchange programs.
    Mark HD; Nanda J; Davis-Vogel A; Navaline H; Scotti R; Wickrema R; Metzger D; Sochalski J
    Public Health Nurs; 2006; 23(1):11-9. PubMed ID: 16460416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychiatric symptoms, risky behavior, and HIV infection.
    Woody GE; Metzger D; Navaline H; McLellan T; O'Brien CP
    NIDA Res Monogr; 1997; 172():156-70. PubMed ID: 9154270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing prevalence of HIV, and persistent high-risk behaviours among drug users in Bangladesh: need for a comprehensive harm reduction programme.
    Islam MM; Conigrave KM
    Drug Alcohol Rev; 2007 Jul; 26(4):445-54. PubMed ID: 17564883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and risk factors of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infections among drug addicts in Bangladesh.
    Shirin T; Ahmed T; Iqbal A; Islam M; Islam MN
    J Health Popul Nutr; 2000 Dec; 18(3):145-50. PubMed ID: 11262767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users.
    Van Den Berg C; Smit C; Van Brussel G; Coutinho R; Prins M;
    Addiction; 2007 Sep; 102(9):1454-62. PubMed ID: 17697278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in human immunodeficiency virus infection among drug users in a detoxification unit.
    Muga R; Sanvisens A; Egea JM; Tor J; Rey-Joly C
    Clin Infect Dis; 2003 Dec; 37 Suppl 5():S404-9. PubMed ID: 14648455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV infection among substance abusers in Thanyarak Institute On Drug Abuse, Thailand, 1987-2002.
    Verachai V; Phutiprawan T; Sawanpanyalert P
    J Med Assoc Thai; 2005 Jan; 88(1):76-9. PubMed ID: 15960222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.